Document is current

Any future updates will be listed below

Metformin selectively inhibits metastatic colorectal cancer with the <i>KRAS</i> mutation by intracellular accumulation through silencing MATE1

Crossref DOI link: https://doi.org/10.1073/pnas.1918845117

Published Online: 2020-05-22

Published Print: 2020-06-09

Update policy: https://doi.org/10.1073/pnas.cm10313

About CrossMark